Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Baxa upgrades DoseEdge Pharmacy Workflow Manager
DoseEdge is the pharmacy workflow management tool that verifies the use of correct drugs, diluents and concentrations in the compounding of IV, chemo, TPN and oral liquid doses.
DoseEdge is the pharmacy workflow management tool that verifies the use of correct drugs, diluents and concentrations in the compounding of IV, chemo, TPN and oral liquid doses.
Intelleflex claimed that the new HMR-9090 Handheld Reader and FMR-6000 Fixed Reader work with the company’s tags to enable wireless, on-demand, product-level monitoring by providing the ability to
Advanced Proteome Therapeutics (APC) has entered into an agreement for a feasibility study with a global pharmaceutical company interested in evaluating APC’s proprietary crosslinking technologies. As per the
Clinical Data said that the issued patent, which will expire in June 2022, covers Vilazodone HC1 in Form IV, its process of preparation and method of treatment therewith.
Sponsored by the US Army Research Office, the grant will allow PolyMedix to conduct further testing on antimicrobial compounds which PolyMedix identified under the initial Phase 1 contract.
AVEO Pharma claims that Tivozanib, an investigational new drug, is a highly potent and selective inhibitor of VEGF receptors 1, 2 and 3, exhibiting picomolar inhibitory activity against
In the Phase I trial, ReNeuron’s ReN001stem cell therapy is being administered to stroke patients who have been left disabled by an ischaemic stroke. The PISCES study (Pilot
VR040 is Vectura’s proprietary formulation of apomorphine, delivered to the bloodstream by inhalation through the lungs using the company’s proprietary dry powder inhalation (DPI) technology. The results of
Biostar Pharma has posted a net income of $3.43m for the third quarter 2010, or $0.13 per diluted share, compared to net income of $3.13m, or $0.13 per
Amlodipine is said to be a calcium channel blocker (dihydropyridine class) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle and is